Testicular Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Conditions:   Lymphadenopathy Retroperitoneal;   Stage II Testicular Seminoma Intervention:   Procedure: Robotic Retroperitoneal Lymph Node Dissection (RPLND) Sponsor:   University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2022 Category: Research Source Type: clinical trials